FDA’s Drug Shortage Anniversary A Happy Occasion For The Agency
This article was originally published in The Pink Sheet Daily
Executive Summary
In the six months since an executive order encouraged firms to provide early notification of potential shortages, FDA has prevented 128 of them, FDA Commissioner Hamburg reports. She attributes the success to manufacturers’ early notification of potential disruptions in drug supply.
You may also be interested in...
User Fee Bill Or Drug Pricing Bill? House Members Makes Both Cases
House passes bill reauthorizing FDA user fee programs via voice vote and makes many other policy changes, but in the process touts the bill's potential to push drug prices lower.
GPhA’s Drug Shortage Initiative Clears FTC Hurdle; Still Working With FDA
Five manufacturers have agreed to give IMS Health production and supply information about drugs in short supply; GPhA and IMS are working with FDA to finalize the details of the accelerated recovery initiative.
GPhA’s Drug Shortage Initiative Clears FTC Hurdle; Still Working With FDA
Five manufacturers have agreed to give IMS Health production and supply information about drugs in short supply; GPhA and IMS are working with FDA to finalize the details of the accelerated recovery initiative.